Business Context and Reporting Period
This Form 6-K filing by Rentokil Initial plc covers the month of March 2026, with a specific reporting date of March 17, 2026. The document serves as a notification of a transaction by a Person Discharging Managerial Responsibilities (PDMR) in accordance with Article 19 of the UK Market Abuse Regulation.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document is strictly a regulatory disclosure regarding insider shareholding.
Material Changes
The material change disclosed is an increase in shareholding by a Non-Executive Director:
- Transaction Type: Purchase of ordinary shares.
- Volume: 2,676 shares.
- Price: £4.828995 per share.
- Total Value: £12,922.39.
- Date: March 16, 2026.
- Venue: London Stock Exchange (XLON).
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, contingencies, or discussion of unusual items. It is a standalone notification of a specific transaction.
Investor Verification Checklist
- Verify the current total shareholding of Sally Johnson to assess the significance of this purchase relative to her total position.
- Confirm the prevailing market price of Rentokil Initial plc shares on March 16, 2026, to validate the transaction price of £4.828995.
- Review the company's latest Form 20-F for broader financial context, as this 6-K does not contain financial statements.